Search





Search





Markets
/
Stocks
/
rntx
/

Rein Therapeutics Inc

RNTX

Add to Watchlist

0.776USD

-0.015-1.92%

Close 07-27 16:00（ET）Quotes delayed by 15 min

21.76MMarket Cap

LossP/E TTM

Rein Therapeutics Inc

0.776

-0.015-1.92%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

RNTX Financials

See Rein Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Rein Therapeutics Inc Earnings Date

Latest Release

May 15, 2026

EPS / Forecast

-0.19/-0.49

Revenue / Forecast

0.00/0.00

See Upcoming Earnings >>

Period

FY2025 Earnings

Revenue(YoY)

EPS(YoY)

-1.96

44.09%

Analyst Rating

BUY

2026/07/27

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

Financial Indicators

EPS

23.38%-0.19

42.18%-1.09

21.56%-0.21

37.20%-0.28

70.70%-0.25

-22.82%-1.89

32.91%-0.27

-14.12%-0.45

18.58%-0.86

-53.62%-1.54

---0.40

---0.39

---1.05

---1.00

---5.02

----

Revenue

--0.00

Net Profit

-6.13%-5.84M

22.00%-31.97M

4.55%-5.58M

23.71%-6.82M

22.66%-5.50M

-458.40%-40.98M

-220.03%-5.85M

-400.39%-8.94M

-48.84%-7.11M

-61.40%-7.34M

71.31%-1.83M

77.64%-1.79M

43.26%-4.78M

33.12%-4.55M

5.01%-6.37M

-40.56%-7.99M

-20.75%-8.42M

-36.09%-6.80M

-33.47%-6.70M

-29.52%-5.69M

Debt to assets ratio

--18.73%

----

Income Statement

Revenue

--0.00

Operating profit

6.76%-5.23M

31.71%-3.96M

9.54%-5.49M

23.98%-6.87M

22.15%-5.61M

20.61%-5.80M

-207.08%-6.07M

-334.57%-9.04M

-80.62%-7.21M

-55.26%-7.30M

69.50%-1.98M

74.13%-2.08M

52.63%-3.99M

31.00%-4.70M

4.55%-6.48M

-33.82%-8.04M

-20.49%-8.42M

-62.60%-6.82M

-35.06%-6.79M

-36.57%-6.01M

Net Profit

-6.13%-5.84M

22.00%-31.97M

4.55%-5.58M

23.71%-6.82M

22.66%-5.50M

-458.40%-40.98M

-220.03%-5.85M

-400.39%-8.94M

-48.84%-7.11M

-61.40%-7.34M

71.31%-1.83M

77.64%-1.79M

43.26%-4.78M

33.12%-4.55M

5.01%-6.37M

-40.56%-7.99M

-20.75%-8.42M

-36.09%-6.80M

-33.47%-6.70M

-29.52%-5.69M

Balance Sheet

Current assets

-34.55%5.45M

-68.32%4.33M

-72.31%5.17M

-71.49%6.60M

-34.73%8.33M

-25.23%13.66M

46.05%18.68M

65.99%23.16M

-25.38%12.76M

-16.49%18.27M

-52.71%12.79M

-58.41%13.95M

-57.23%17.11M

-54.60%21.87M

-50.29%27.05M

-44.22%33.55M

-37.83%39.99M

195.09%48.18M

240.70%54.42M

205.81%60.15M

Total current liabilities

128.16%13.64M

7.50%6.18M

1.50%5.74M

55.84%7.69M

31.88%5.98M

31.11%5.75M

248.46%5.66M

312.45%4.94M

57.14%4.53M

29.58%4.38M

-64.20%1.62M

-76.76%1.20M

-30.44%2.88M

-24.93%3.38M

-0.53%4.54M

20.55%5.15M

34.92%4.15M

13.84%4.51M

-13.13%4.56M

-13.26%4.27M

Total assets

-54.38%26.29M

-61.15%24.16M

-48.47%53.71M

-47.46%57.48M

-41.90%57.63M

-41.33%62.19M

712.80%104.22M

681.93%109.40M

478.14%99.19M

381.70%106.01M

-52.92%12.82M

-58.57%13.99M

-57.38%17.16M

-54.61%22.01M

-50.28%27.23M

-44.21%33.77M

-37.75%40.26M

196.68%48.48M

146.27%54.77M

131.70%60.53M

Total liabilities

89.66%14.70M

-7.16%7.24M

-16.35%7.52M

12.97%9.47M

-1.39%7.75M

1.13%7.80M

453.26%8.98M

600.00%8.38M

172.47%7.86M

127.87%7.71M

-64.20%1.62M

-76.76%1.20M

-30.44%2.88M

-26.07%3.38M

-2.64%4.54M

17.04%5.15M

27.49%4.15M

9.52%4.58M

-52.37%4.66M

-53.53%4.40M

Total equity

-76.76%11.59M

-68.90%16.92M

-51.50%46.19M

-52.47%48.01M

-45.39%49.88M

-44.67%54.39M

750.44%95.23M

689.60%101.02M

539.91%91.33M

427.83%98.30M

-50.66%11.20M

-55.30%12.79M

-60.47%14.27M

-57.58%18.62M

-54.71%22.70M

-49.01%28.62M

-41.21%36.11M

260.99%43.90M

302.22%50.11M

237.04%56.13M

Cash Flow Statement

Net operating income

44.55%-3.42M

33.08%-3.22M

7.10%-3.55M

23.50%-6.42M

-17.15%-6.17M

53.69%-4.81M

-132.87%-3.82M

-169.22%-8.39M

-13.09%-5.27M

-135.68%-10.39M

76.47%-1.64M

45.19%-3.12M

40.24%-4.66M

29.51%-4.41M

3.98%-6.97M

-51.08%-5.69M

-20.44%-7.80M

-33.40%-6.25M

-43.96%-7.26M

25.81%-3.76M

Net investment

----

100.00%0.00

-100.00%0.00

-102.02%-96.00K

-87.04%542.00K

44.95%8.50M

-37.76%7.25M

111.64%4.76M

2.27%4.18M

222.22%5.86M

131.10%11.65M

730.53%2.25M

190.28%4.09M

-2107.53%-4.80M

Net financing

530.62%4.65M

240400.00%2.40M

526.01%1.90M

-74.20%4.71M

--738.00K

-99.99%1.00K

---446.00K

--18.26M

----

--15.79M

--0.00

-100.00%0.00

-99.98%1.00K

-91.28%26.00K

-99.77%26.00K

FAQs

What are the current assets of Rein Therapeutics Inc?



According to Rein Therapeutics Inc's FY2025 earnings report, its current assets were 4.33M, with a year-on-year change of -68.32.

What are the total assets of Rein Therapeutics Inc?



According to Rein Therapeutics Inc's FY2025 earnings report, its total assets of Rein Therapeutics Inc were 24.16M, with a year-on-year change of -61.15.

What are the total liabilities of Rein Therapeutics Inc?



According to Rein Therapeutics Inc's FY2025 earnings report, its total liabilities of Rein Therapeutics Inc were 7.24M, with a year-on-year change of -7.16.

What is the total equity of Rein Therapeutics Inc?



According to Rein Therapeutics Inc's FY2025 earnings report, its total equity of Rein Therapeutics Inc was 16.92M, with a year-on-year change of -68.90.

What is the net operating income of Rein Therapeutics Inc?



According to Rein Therapeutics Inc's FY2025 earnings report, its net operating income of Rein Therapeutics Inc was -21.93M, with a year-on-year change of 21.99.

What is the net financing of Rein Therapeutics Inc?



According to Rein Therapeutics Inc's FY2025 earnings report, its net financing of Rein Therapeutics Inc was 9.76M, with a year-on-year change of -45.25.

What is the Earnings Per Share (EPS) of Rein Therapeutics Inc?



According to Rein Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.96, with a year-on-year change of 44.09.

What is the net income of Rein Therapeutics Inc?



According to Rein Therapeutics Inc's FY2025 earnings report, its net income was -49.87M, with a year-on-year change of 20.69.

What is the Return on Assets (ROA) of Rein Therapeutics Inc?



According to Rein Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -115.51, with a year-on-year change of -54.48.

What is the operating profit of Rein Therapeutics Inc?



According to Rein Therapeutics Inc's FY2025 earnings report, its operating profit was -21.93M, with a year-on-year change of 21.99.